Vetter consolidates development labs in one location

By Ben Hargreaves contact

- Last updated on GMT

(Image: Getty/NirutiStock)
(Image: Getty/NirutiStock)

Related tags: vetter, Germany, CDMO

Vetter decides to house its development laboratories together in Ravensburg, Germany, to modernize capabilities, with plans for further expansion.

The new building space was completed last year and sees Vetter’s development laboratories housed in one 1,800-square-meter facility in Ravensburg.

The facilities include non-good manufacturing practice (GMP) laboratory space and equipment, as well as a GMP analytical laboratory. In addition, the combined space will offer process development capabilities, as well as specification testing of packaging system, chemical-analytical and biochemical analysis and particle characterization.

In total, 50 employees will staff the building and the contract development and manufacturing organization (CDMO) noted that being housed under one roof will allow colleagues to “share expertise and know-how to improve and simplify information exchange.”

As well as improving cooperation, the merged lab space is expected to reduce handling issues and allow for the synchronization of processes, as previously development took place in different locations in Ravensburg and Langenargen.

Customers will benefit by being able to follow the development cycle of their project, suggested Claus Feussner, SVP of Development Service.

“Now [clients] can follow a complete development process and its individual steps, since it proceeds throughout the labs, all within the same building,”​ he said.

Though the new building is complete, the company will continue to expand within the space over the course of 2020 and will add further analytical equipment.

The investment in its European capabilities follows similar investment in its US operations, which saw it expand its clinical manufacturing facility in Chicago last year​. The company also launched a pilot project looking at automating its packaging services​.

Related news

Show more

Related products

show more

Liver Disease Capabilities

Liver Disease Capabilities

Q² Solutions | 01-Oct-2020 | Clinical Study

We integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize NAFLD & NASH study design,...

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 21-Sep-2020 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

Related suppliers

Follow us

Products

View more

Webinars